IFN alpha:Fc (Syntonix)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIFN alpha:Fc (Syntonix)

Drug Alias Nameinterferon alpha:Fc fusion (Syntonix)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionInterferon alpha ligand

TargetsInterferon alpha

Therapy Area/IndicationsNeoplasmsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBioverativ Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBioverativ Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsNeoplasmsHepatitis C

Other Information

ATC CodeN/A